ES2055962T5 - Preparado farmaceutico de liberacion controlada. - Google Patents
Preparado farmaceutico de liberacion controlada.Info
- Publication number
- ES2055962T5 ES2055962T5 ES91305834T ES91305834T ES2055962T5 ES 2055962 T5 ES2055962 T5 ES 2055962T5 ES 91305834 T ES91305834 T ES 91305834T ES 91305834 T ES91305834 T ES 91305834T ES 2055962 T5 ES2055962 T5 ES 2055962T5
- Authority
- ES
- Spain
- Prior art keywords
- controlled release
- pharmaceutical preparation
- water
- medicinal compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
- Stringed Musical Instruments (AREA)
- Pens And Brushes (AREA)
Abstract
SE PRESENTA UNA PREPARACION FARMACEUTICA DE LIBERACION CONTROLADA QUE COMPRENDE UN NUCLEO QUE CONTIENE UN COMPUESTO MEDICINAL Y UNA CAPA DE RECUBRIMIENTO QUE CONTIENE UNA SAL REPELENTE DEL AGUA Y UN POLIMERO ACRILICO INSOLUBLE EN AGUA Y LIGERAMENTE PERMEABLE A LA MISMA QUE TIENE UN GRUPO TRIMETIL AMONIOMETIL. DICHA PREPARACION LIBERA UN COMPUESTO MEDICINAL EN UNA FORMA DE DISOLUCION DE TIPO SIGMOIDE CON INDEPENDENCIA DEL PH DEL MEDIO DE DISOLUCION.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17176290 | 1990-06-28 | ||
SG4995A SG4995G (en) | 1990-06-28 | 1995-01-13 | Controlled release pharmaceutical preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2055962T3 ES2055962T3 (es) | 1994-09-01 |
ES2055962T5 true ES2055962T5 (es) | 1997-09-16 |
Family
ID=26494375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91305834T Expired - Lifetime ES2055962T5 (es) | 1990-06-28 | 1991-06-27 | Preparado farmaceutico de liberacion controlada. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5137733A (es) |
EP (1) | EP0463877B2 (es) |
JP (1) | JP2558396B2 (es) |
KR (1) | KR0133511B1 (es) |
CN (1) | CN1040061C (es) |
AT (1) | ATE106241T1 (es) |
CA (1) | CA2045358C (es) |
DE (1) | DE69102211T3 (es) |
DK (1) | DK0463877T3 (es) |
ES (1) | ES2055962T5 (es) |
FI (1) | FI103476B1 (es) |
GR (1) | GR3024471T3 (es) |
HK (1) | HK33895A (es) |
HU (1) | HU214590B (es) |
IE (1) | IE64629B1 (es) |
IL (1) | IL98611A (es) |
SG (1) | SG4995G (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US7070806B2 (en) | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
CN1053808C (zh) * | 1993-04-24 | 2000-06-28 | 章修纲 | 尼非地平控释剂型 |
JP2916978B2 (ja) * | 1993-08-25 | 1999-07-05 | エスエス製薬株式会社 | 放出開始制御型製剤 |
US5834024A (en) * | 1995-01-05 | 1998-11-10 | Fh Faulding & Co. Limited | Controlled absorption diltiazem pharmaceutical formulation |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
US6486177B2 (en) * | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US5830503A (en) * | 1996-06-21 | 1998-11-03 | Andrx Pharmaceuticals, Inc. | Enteric coated diltiazem once-a-day formulation |
US6962997B1 (en) * | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
ES2263211T3 (es) | 1997-07-02 | 2006-12-01 | Euro-Celtique S.A. | Formulaciones de tramadol de liberacion sostenida estabilizada. |
AU2546399A (en) | 1998-02-10 | 1999-08-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
FR2778848B1 (fr) * | 1998-05-20 | 2001-11-23 | Prographarm Lab | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US20010055613A1 (en) * | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
US6270805B1 (en) | 1998-11-06 | 2001-08-07 | Andrx Pharmaceuticals, Inc. | Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
US6039979A (en) * | 1999-01-13 | 2000-03-21 | Laboratoires Prographarm | Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation |
ATE329589T1 (de) * | 1999-01-21 | 2006-07-15 | Athpharma Ltd | Multipartikuläre bisoprolol formulierung |
US6733789B1 (en) | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
SK8562002A3 (en) | 1999-12-23 | 2003-10-07 | Pfizer Prod Inc | Pharmaceutical compositions providing enhanced drug concentrations |
ES2302705T3 (es) * | 1999-12-23 | 2008-08-01 | Pfizer Products Inc. | Forma de dosificacion de farmaco distribuido por un hidrogel. |
US20040185099A1 (en) * | 2000-01-20 | 2004-09-23 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
US6635277B2 (en) | 2000-04-12 | 2003-10-21 | Wockhardt Limited | Composition for pulsatile delivery of diltiazem and process of manufacture |
US6984402B2 (en) | 2000-10-03 | 2006-01-10 | Elite Laboratories, Inc. | Chrono delivery formulations and method of treating atrial fibrillation |
US6620439B1 (en) * | 2000-10-03 | 2003-09-16 | Atul M. Mehta | Chrono delivery formulations and method of use thereof |
SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
US7125561B2 (en) * | 2001-05-22 | 2006-10-24 | Euro-Celtique S.A. | Compartmentalized dosage form |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US20030091633A1 (en) * | 2001-11-15 | 2003-05-15 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
US20030118652A1 (en) * | 2001-11-15 | 2003-06-26 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
US6663888B2 (en) * | 2001-12-14 | 2003-12-16 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
US20050025824A1 (en) * | 2001-12-14 | 2005-02-03 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US7365059B2 (en) * | 2003-03-11 | 2008-04-29 | Seikagaku Corporation | Photocrosslinked-polysaccharide composition and production process of the same |
PL1631251T3 (pl) | 2003-04-24 | 2011-12-30 | Jagotec Ag | Tabletka o opóźnionym uwalnianiu i o określonej geometrii |
FR2861990B1 (fr) * | 2003-11-10 | 2006-02-10 | Nouveaux Produits Pharma | Comprimes faiblement doses a reseau de polymeres |
US20050239830A1 (en) * | 2004-04-26 | 2005-10-27 | Vikram Khetani | Methods of diminishing co-abuse potential |
JP4722837B2 (ja) * | 2004-05-07 | 2011-07-13 | 生化学工業株式会社 | 髄核充填剤 |
DE102004043863A1 (de) | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ709754A (en) | 2004-10-21 | 2017-02-24 | Adare Pharmaceuticals Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
CA2591247A1 (en) * | 2004-12-09 | 2006-06-15 | Celgene Corporation | Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US8846100B2 (en) * | 2006-05-12 | 2014-09-30 | Shire Llc | Controlled dose drug delivery system |
WO2008015018A1 (en) | 2006-08-03 | 2008-02-07 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease |
JP2008024708A (ja) * | 2007-08-20 | 2008-02-07 | Euro-Celtique Sa | アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法 |
MX339852B (es) * | 2008-11-18 | 2016-06-15 | Ucb Pharma Sa | Formulaciones de liberacion prolongada que comprenden un derivado de 2-oxo-1-pirrolidina. |
BRPI1001091A2 (pt) * | 2009-04-22 | 2011-03-22 | Dr Suwelack Skin & Health Care Ag | artigo moldado revestido secado por congelamento |
SG10201407965XA (en) | 2009-12-02 | 2015-02-27 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
EP2647648B1 (en) * | 2010-12-03 | 2017-08-09 | Nippon Soda Co., Ltd. | Solid dosage form containing a low viscosity HYDROXYALKYL CELLULOSE |
US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
ES2644942T3 (es) | 2011-03-23 | 2017-12-01 | Ironshore Pharmaceuticals & Development, Inc. | Métodos y composiciones para el tratamiento del trastorno por déficit de atención |
US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
JP5146859B2 (ja) * | 2011-07-11 | 2013-02-20 | ユーロ−セルティーク エス.エイ. | アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法 |
CA2902911C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5944311A (ja) * | 1982-09-07 | 1984-03-12 | Santen Pharmaceut Co Ltd | 徐放性顆粒およびその製造法 |
US5002776A (en) * | 1983-12-22 | 1991-03-26 | Elan Corporation, Plc | Controlled absorption diltiazem formulations |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US4559225A (en) * | 1984-02-16 | 1985-12-17 | Fourman Robert G | Sunscreen composition |
JPH0621066B2 (ja) * | 1984-03-14 | 1994-03-23 | 杏林製薬株式会社 | 3―イソブチリル―2―イソプロピルピラゾロ〔1,5―a〕ピリジンの徐放性医薬品組成物 |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
GB8707416D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
ATE79029T1 (de) * | 1989-02-11 | 1992-08-15 | Bayer Ag | Arzneimittel mit kontrollierter wirkstoffabgabe. |
US4983401A (en) * | 1989-05-22 | 1991-01-08 | Kinaform Technology, Inc. | Sustained release pharmaceutical preparations having pH controlled membrane coatings |
US5013557A (en) * | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
-
1991
- 1991-06-11 JP JP3138998A patent/JP2558396B2/ja not_active Expired - Lifetime
- 1991-06-18 FI FI912952A patent/FI103476B1/fi not_active IP Right Cessation
- 1991-06-21 IE IE216691A patent/IE64629B1/en not_active IP Right Cessation
- 1991-06-25 CA CA002045358A patent/CA2045358C/en not_active Expired - Lifetime
- 1991-06-25 IL IL9861191A patent/IL98611A/en not_active IP Right Cessation
- 1991-06-27 ES ES91305834T patent/ES2055962T5/es not_active Expired - Lifetime
- 1991-06-27 AT AT91305834T patent/ATE106241T1/de not_active IP Right Cessation
- 1991-06-27 EP EP91305834A patent/EP0463877B2/en not_active Expired - Lifetime
- 1991-06-27 DK DK91305834.3T patent/DK0463877T3/da active
- 1991-06-27 DE DE69102211T patent/DE69102211T3/de not_active Expired - Lifetime
- 1991-06-27 HU HU912170A patent/HU214590B/hu unknown
- 1991-06-28 KR KR1019910010955A patent/KR0133511B1/ko not_active IP Right Cessation
- 1991-06-28 CN CN91105399A patent/CN1040061C/zh not_active Expired - Lifetime
- 1991-06-28 US US07/723,031 patent/US5137733A/en not_active Expired - Lifetime
-
1995
- 1995-01-13 SG SG4995A patent/SG4995G/en unknown
- 1995-03-09 HK HK33895A patent/HK33895A/xx not_active IP Right Cessation
-
1997
- 1997-08-14 GR GR970402109T patent/GR3024471T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69102211T3 (de) | 1997-08-28 |
ATE106241T1 (de) | 1994-06-15 |
HUT59321A (en) | 1992-05-28 |
IE912166A1 (en) | 1992-01-01 |
DE69102211D1 (de) | 1994-07-07 |
EP0463877B1 (en) | 1994-06-01 |
SG4995G (en) | 1995-06-16 |
HU214590B (hu) | 1998-04-28 |
JPH04235123A (ja) | 1992-08-24 |
HK33895A (en) | 1995-03-17 |
DE69102211T2 (de) | 1994-09-15 |
CN1058533A (zh) | 1992-02-12 |
JP2558396B2 (ja) | 1996-11-27 |
FI912952A (fi) | 1991-12-29 |
IL98611A0 (en) | 1992-07-15 |
AU7924391A (en) | 1992-01-02 |
EP0463877B2 (en) | 1997-07-02 |
IE64629B1 (en) | 1995-08-23 |
IL98611A (en) | 1998-10-30 |
CA2045358C (en) | 1998-04-28 |
US5137733A (en) | 1992-08-11 |
EP0463877A1 (en) | 1992-01-02 |
CN1040061C (zh) | 1998-10-07 |
CA2045358A1 (en) | 1991-12-29 |
FI103476B (fi) | 1999-07-15 |
DK0463877T3 (da) | 1994-06-27 |
FI912952A0 (fi) | 1991-06-18 |
GR3024471T3 (en) | 1997-11-28 |
KR920000313A (ko) | 1992-01-29 |
HU912170D0 (en) | 1991-12-30 |
KR0133511B1 (ko) | 1998-04-23 |
FI103476B1 (fi) | 1999-07-15 |
ES2055962T3 (es) | 1994-09-01 |
AU634400B2 (en) | 1993-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2055962T3 (es) | Preparado farmaceutico de liberacion controlada. | |
SE8404467D0 (sv) | Controlled-release medical preparations | |
ATE92312T1 (de) | Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung. | |
ES2001897A6 (es) | Procedimiento para la fabricacion de una tableta de liberacion controlada | |
DE69624047D1 (de) | Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel | |
ATE67408T1 (de) | Arzneimittel mit verzoegerter freigabe in oraler dosisform. | |
DE69323428D1 (de) | Morphinzubereitungen mit kontrollierter freisetzung | |
ATE68343T1 (de) | Darreichungsform mit kontrollierter freigabe. | |
DK1169032T3 (da) | Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater | |
FI973107A0 (fi) | Hallitusti vapautuvat vesiympäristön ravintoaineet | |
DE3889711D1 (de) | Oberflächenbehandlung eines PET-Filmes. | |
DE69105595D1 (de) | Vorrichtung versehen mit einer photorefraktiven polymeren Dünnschicht zur Behandlung von dynamischen Hologrammen. | |
ATE10165T1 (de) | System zur kontrollierten freigabe einer biologisch aktiven substanz in einer koerperfluessigkeit. | |
CA2124425A1 (en) | Pharmaceutical Tablets Releasing the Active Substance After a Definite Period of Time |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 463877 Country of ref document: ES |